Exploring how physical activity affects patients with pulmonary arterial hypertension
Official title: Physical activity phenotypes and their association with traditional outcomes in pulmonary arterial hypertension
Funded at University of Pennsylvania · NIH-10887023 · Data updated 2026-11-12
This study is looking at how different types of exercise affect the health of people with pulmonary arterial hypertension (PAH) by using a special device to track their heart rates and activity levels at home, so we can find ways to help them feel better and live healthier lives.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project start | July 1, 2024 |
| Project end | June 30, 2029 |
| Funding year | 2024 |
| Award (this year) | $192,231 |
| NIH project number | 1K23HL169930-01A1 |
| Project ID | NIH-10887023 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals aged 65 and older who have been diagnosed with pulmonary arterial hypertension.
✕Less likely to help
Patients who are younger than 65 or do not have a diagnosis of pulmonary arterial hypertension may not benefit from this research.
What this research studies
This research investigates how different patterns of physical activity relate to health outcomes in patients with pulmonary arterial hypertension (PAH). Using a non-invasive biosensor device, the study continuously monitors patients' heart rates, respiratory rates, and activity levels in their home environments. The goal is to understand how daily physical activity impacts patients' lives and to identify personalized interventions that can help improve their overall health. Additionally, the research will gather insights on patients' attitudes towards these interventions to tailor approaches that best fit their needs.
Why it matters
Potential benefit: If successful, this research could lead to personalized strategies that enhance physical activity and improve health outcomes for patients with pulmonary arterial hypertension.
How similar studies have gone: Previous research has shown promise in using wearable technology to monitor health outcomes, suggesting that this approach could yield valuable insights for PAH management.
Where this research is happening
-
University of Pennsylvania
Philadelphia, United States Active
Researchers
- Principal investigator: Minhas, Jasleen — University of Pennsylvania
- Study coordinator: Minhas, Jasleen
Related research
Other NIH-funded projects on the same topics.
-
Understanding how blood flow and pressure affect lungs in PAH
This grant studies how abnormal blood flow and pressure contribute to pulmonary arterial hypertension and how patient factors shape these effects, with the aim of guiding better therapies.
-
Asporin as a double-targeted therapy and biomarker for a serious artery disease
This project tests a protein called asporin as both a treatment and a biomarker for pulmonary arterial hypertension (PAH) to help people with this life-threatening condition.
-
Platelets and fibroblasts linked to energy use in a hard-to-treat blood vessel disease
A research team at the University of Pittsburgh is studying how platelet energy metabolism and fibroblast glutamine use interact in systemic sclerosis-related pulmonary arterial hypertension to improve diagnosis and treatment.
-
A biatrial dual‑lumen catheter to help the heart and lungs in pulmonary arterial hypertension
A new double‑lumen catheter is being developed to unload the right side of the heart and protect the lungs for people with pulmonary arterial hypertension.
-
Endothelial inflammation and Src kinase in early pulmonary arterial hypertension
Researchers are studying how inflammation in the lining of blood vessels and a protein called Src kinase contribute to early lung artery remodeling in people with mild PAH.
-
Cardiopulmonary chip model to study right heart disease from high blood pressure in the lungs
A tiny heart-lung chip is being developed to understand why the right side of the heart enlarges in people with pulmonary arterial hypertension and to test targeted treatments.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.